Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, CXP

Sekisui Diagnostics Opens $1.9 Million Bioprocess Innovation Centre

BURLINGTON, Massachusetts, Nov. 25, 2019 /PRNewswire/ -- Sekisui Diagnostics' Enzyme business unveiled its new Bioprocess Innovation Centre at its site near Maidstone, Kent, UK. The new R&D facility, costing $1.9 million, is part of a long-term investment strategy to grow its share of the Microbial Biopharma CDMO market, with future investment expected to focus on expanding its cGMP manufacturing capabilities, starting with additional ISO 8 clean room capacity coming online by the end of 2019.

BioProcess Innovation Centre

The new Bioprocess Innovation Centre includes 250m2 of laboratory space and 134m2 of office space, more than doubling its R&D laboratory space to facilitate Process Transfer and Development.

The new facility includes dedicated and separate microbial fermentation development, protein purification, analysis and molecular biology laboratories.

Sekisui's Biopharma CDMO service offering, BioProduction by Sekisui, is focused on expression and purification from microbial fermentation. Building on over 40 years' experience in this field, the group's expertise lies in the production of enzymes, however its capabilities are also suitable for plasmids, antibody fragments, and other protein production.

"This investment represents our commitment to serve our customers with innovative process development solutions," said Will Stockburn, Sekisui Diagnostics (UK) Ltd.'s General Manager. "Over many years we have built a technical competency in enzyme production process development. The new facility will enable our team to attract more customers as the Biopharma CDMO market grows."

About Sekisui Diagnostics

Sekisui Diagnostics is a global company committed to improving patient's lives by providing innovative medical diagnostics to physicians and laboratories through a global commercial network.  Product lines include clinical chemistry and coagulation systems, reagents, rapid test kits, point-of-care systems. The Enzyme business forms part of this group and, in addition to BioProduction by Sekisui, offers a broad portfolio of Diagnostic enzymes and critical raw materials.


Sekisui Diagnostics Logo

Photo - https://mma.prnewswire.com/media/1033976/BioProcess.jpg 
Logo - https://mma.prnewswire.com/media/412597/sekisui_diagnostics_logo.jpg

These press releases may also interest you

at 00:00
Gulf Business Machines (GBM), a leading end-to-end digital solutions provider, offering industry-leading digital infrastructure, digital business solutions, security and services, has been recently recognized as one of the best places to work for in...

8 aoû 2020
General Dynamics announced today that the negotiating teams from Bath Iron Works and the International Association of Machinists and Aerospace Workers (IAM) Local S6 reached agreement last night on mutually acceptable terms to end the ongoing strike...

8 aoû 2020
In a recent video on his YouTube channel, Deadbeat Inc. founder Dan Brock explains how to survive the pandemic by building a recession proof eCommerce business. You'll uncover the kinds of niche markets thriving right now, how to get visitors for...

8 aoû 2020
SID Display Week, the most influential tradeshow for the global display community, presented the first ever virtual show on August 3, 2020. BOE showed a slew of its innovative display technologies and applications such as printing OLED, flexible...

8 aoû 2020
Many drivers are wondering if the minimum car insurance is enough to protect them. The majority of them prefer to buy only the minimum required liability coverage. However, in some cases, the liability coverage will not be enough to pay for the costs...

8 aoû 2020
Horizon Engineering Associates, LLP (HEA), a professional engineering firm specializing in commissioning, energy consulting and LEED services, is pleased to announce its recent hire of Mr. Colin Milner, CEM, CBCP, MFBA, who has joined the HEA team as...

News published on 25 november 2019 at 08:00 and distributed by: